113 related articles for article (PubMed ID: 8616031)
21. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.
Hunger SP; Galili N; Carroll AJ; Crist WM; Link MP; Cleary ML
Blood; 1991 Feb; 77(4):687-93. PubMed ID: 1671560
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a new human pre-B acute lymphoblastic leukemia cell line (KMO-90) with 1;19 translocation carrying p53 gene alterations.
Sotomatsu M; Hayashi Y; Kawamura M; Yugami S; Shitara T
Leukemia; 1993 Oct; 7(10):1615-20. PubMed ID: 8412323
[TBL] [Abstract][Full Text] [Related]
23. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X
Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861
[TBL] [Abstract][Full Text] [Related]
24. Genetic changes: relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia.
Cole-Sinclair MF; Foroni L; Hoffbrand AV
Baillieres Clin Haematol; 1994 Jun; 7(2):183-233. PubMed ID: 7803899
[TBL] [Abstract][Full Text] [Related]
25. [Childhood acute lymphoblastic leukemia with t(1;19) lacking E2A-pBX1 chimeric transcripts].
Matsubara K; Hirata T
Rinsho Ketsueki; 2005 Jan; 46(1):7-12. PubMed ID: 16708911
[TBL] [Abstract][Full Text] [Related]
26. Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21).
Satake N; Kobayashi H; Tsunematsu Y; Kawasaki H; Horikoshi Y; Koizumi S; Kaneko Y
Br J Haematol; 1997 Jun; 97(3):607-11. PubMed ID: 9207408
[TBL] [Abstract][Full Text] [Related]
27. [E2A gene in t(1;19)-ALL].
Hayashi Y
Nihon Rinsho; 1992 Jun; 50(6):1369-73. PubMed ID: 1355570
[TBL] [Abstract][Full Text] [Related]
28. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
[TBL] [Abstract][Full Text] [Related]
29. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
[TBL] [Abstract][Full Text] [Related]
30. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
Yang YL; Lin SR; Chen JS; Hsiao CC; Lin KH; Sheen JM; Cheng CN; Wu KH; Lin SW; Yu SL; Chen HY; Lu MY; Chang HH; Yen CT; Lin JF; Su YH; Li YP; Lin CY; Jou ST; Lin DT
J Pediatr Hematol Oncol; 2010 Nov; 32(8):e323-30. PubMed ID: 20930648
[TBL] [Abstract][Full Text] [Related]
31. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia.
Numata S; Kato K; Horibe K
Leukemia; 1993 Sep; 7(9):1441-4. PubMed ID: 8103813
[TBL] [Abstract][Full Text] [Related]
32. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction.
Brisco MJ; Condon J; Hughes E; Neoh SH; Sykes PJ; Seshadri R; Toogood I; Waters K; Tauro G; Ekert H
Lancet; 1994 Jan; 343(8891):196-200. PubMed ID: 7904666
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of the t(1;19)(q23;p13) translocation observed in adult leukemias.
Mitani K; Sasaki K; Ogawa S; Hayashi Y; Mano H; Yazaki Y; Hirai H
Int J Hematol; 1994 Dec; 60(4):267-71. PubMed ID: 7894030
[TBL] [Abstract][Full Text] [Related]
34. [Real-time quantitative detection of E2A-PBX1 fusion gene in children with acute lymphoblastic leukemia and its clinical application in minimal residual disease monitoring].
Zhang R; Liao J; Li G; Sun HQ; Shi YJ; Yang JY
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):440-3. PubMed ID: 23791058
[TBL] [Abstract][Full Text] [Related]
35. A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse.
Jacquy C; Delepaut B; Van Daele S; Vaerman JL; Zenebergh A; Brichard B; Vermylen C; Cornu G; Martiat P
Br J Haematol; 1997 Jul; 98(1):140-6. PubMed ID: 9233577
[TBL] [Abstract][Full Text] [Related]
36. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T
Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105
[TBL] [Abstract][Full Text] [Related]
37. Rearrangement of the E2A gene in the t (1;19) acute lymphoblastic leukemia.
Jonveaux P; Berger R
Nouv Rev Fr Hematol (1978); 1991; 33(6):547-9. PubMed ID: 1818313
[TBL] [Abstract][Full Text] [Related]
38. A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia.
Cimino G; Elia L; Rapanotti MC; Sprovieri T; Mancini M; Cuneo A; Mecucci C; Fioritoni G; Carotenuto M; Morra E; Liso V; Annino L; Saglio G; De Rossi G; Foà R; Mandelli F
Blood; 2000 Jan; 95(1):96-101. PubMed ID: 10607691
[TBL] [Abstract][Full Text] [Related]
39. Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL).
Shahkarami S; Mehrasa R; Younesian S; Yaghmaie M; Chahardouli B; Vaezi M; Rezaei N; Nikbakht M; Alimoghaddam K; Ghavamzadeh A; Tavakkoly-Bazzaz J; Ghaffari SH
Ann Hematol; 2018 Apr; 97(4):585-595. PubMed ID: 29392424
[TBL] [Abstract][Full Text] [Related]
40. [Detection of minimal residual disease using reverse transcriptase polymerase chain reaction technique].
Numata S; Kato K; Horibe K
Nihon Rinsho; 1992 Jun; 50(6):1380-5. PubMed ID: 1381448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]